Find investors who align with your industry, stage, and vision. Unlock Maria Berkman’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayMaria Berkman is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics, Gila Therapeutics, Herantis Pharma, Aria CVRemedy Pharmaceuticals, Apama Medical, CroíValve, ZZ Biotech, Adient Medical, HAYA Therapeutics, Intravascular Imaging Incorporated, NIDO, G.I. Windows, NuPulseCV, 480 Biomedical, Cardero Therapeutics, Epirium Bio, Allosteros, AtaCor Medical, Alleviant Medical, CardiaLen, Aggamin Biologics, Mellitus, Broadview Ventures Inc, Basking Biosciences, InfoBionic, Vectorious Medical Technologies, Ischemia Care, Capricor Therapeutics, CellAegis Devices, Renovacor, Vascular Graft Solutions, CardiAQ Valve Technologies, Antag Therapeutics, Ventrinova, Pulmokine, BioKier, Zumbro Discovery, Viridian Therapeutics, Acesion Pharma, Aeromics, Longview Ventures, . Over time, Maria Berkman has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Maria Berkman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Data Science, Wellness, Women Founded, HR Tech, Healthcare Innovation, Life Science, Medical Technologies, Manufacturing, Biotechnology, Consumer Health, Medical Devices, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Research, Digital Health, Medical, Information Technology, B2B, Therapeutics, Health Tech, Pharmaceuticals may find it worthwhile to explore potential connections with Maria Berkman, as their portfolio suggests a familiarity and interest in this area.
Understanding Maria Berkman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today